Recent in silico evidence suggests that vitamin D receptor (VDR) super-enhancers (VSE) may be influenced by nearby MS risk SNPs, thereby impacting the activity of these VSEs in relation to disease (25). This evidence concerns the gene VDR and myeloid sarcoma.